Research and Markets: PharmaPoint Report: Rheumatoid Arthritis - Current and Future Players

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/rcqgpq/pharmapoint) has announced the addition of GlobalData's new report "PharmaPoint: Rheumatoid Arthritis - Current and Future Players" to their offering.

“PharmaPoint: Rheumatoid Arthritis - Current and Future Players”

PharmaPoint: Rheumatoid Arthritis - Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Rheumatoid Arthritis Market. The report identifies and analyses the key companies shaping and driving the global Rheumatoid Arthritis market. The report provides insight into the competitive Rheumatoid Arthritis landscape, including new companies entering the market.

Scope

- Investigation of current and future market competition for Rheumatoid Arthritis

- Competitor assessment

- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.

- Strategic assessment of the Rheumatoid Arthritis sector through market impact analysis, future market scenario and company analysis

Reasons to buy

- Gain a high level view of the trends shaping and driving the Rheumatoid Arthritis Market

- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.

- Create an effective counter-strategy to gain a competitive advantage against those currently in the market

- What's the next big thing in the global Rheumatoid Arthritis market landscape? Identify, understand and capitalize

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Market Outlook

3.1 Global Markets

3.1.1 Forecast

3.1.2 Drivers and Barriers - Global Issues

4 Current and Future Players

4.1 Overview

4.2 Trends in Corporate Strategy

4.3 Company Profiles

4.3.1 Abbott

4.3.2 Pfizer

4.3.3 Amgen

4.3.4 Johnson & Johnson

4.3.5 Eli Lilly

4.3.6 Bristol-Myers Squibb (BMS)

4.3.7 UCB

4.3.8 Roche

4.3.9 GlaxoSmithKline

5 Appendix

For more information visit http://www.researchandmarkets.com/research/rcqgpq/pharmapoint

Source: GlobalData